Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-06-16

Clinical Trial Update: ATP Release and Sympathetic Nerve Activity in Patients With Type II Diabetes [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial investigating ATP release and sympathetic nerve activity in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Anders Rasmussen Rinnov | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: UNKNOWN